相关实验视频

Updated: Sep 13, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

国家阿尔茨海默氏症协调中心脑神经病理学和心房动中的认知功能

Kathryn A Wood¹, Xinyue Chen², Yi-An Ko²

¹Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA.

Journal of Alzheimer's disease : JAD

|August 1, 2025

概括

心房动 (AF) 与痴呆风险有关,但这项研究没有发现任何证据表明AF直接导致与阿尔茨海默病 (AD) 相关的斑块或结等脑部变化. 需要进一步的研究来理解这种复杂的关系.

科学领域:

神经学神经学
心脏病学心脏病学
病理学病理学病理学

背景情况:

心房动 (AF) 是痴呆症和阿尔茨海默病 (AD) 的已知危险因素.
关联AF与认知衰退的潜在机制尚不清楚.
神经病理学检查对于了解疾病过程至关重要.

研究的目的:

调查大脑尸检队列中心房动 (AF) 和特定神经病理标志物之间的关联.
确定AF是否与初级痴呆相关的大脑病理有关,例如神经质斑块密度和神经纤维状结进展.

主要方法:

利用了国家阿尔茨海默氏症协调中心 (NACC) 的脑尸检队列,包括3558名受试者.
采用后勤和顺序后勤回归分析来评估AF和神经病理学之间的关系.
检查了CERAD神经质斑块密度,布拉克得分和NIA/里根得分.

主要成果:

前庭动 (AF) 与CERAD神经质斑块密度的差异有显著的关联.
患有AF的受试者表现出更高的Braak和NIA/里根得分,这表明神经病理可能更糟.
在多次测试调整后,这些关联在统计学上没有显著意义.

结论:

这些发现表明,与AF相关的痴呆风险增加不太可能直接由原发性阿尔茨海默病相关的神经病理机制调解.
需要进一步的研究来阐明AF和认知障碍之间的复杂关系.
这项研究强调了在神经退行性疾病的背景下考虑心血管健康的重要性.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.粉样蛋白质斑块是一种粉样蛋白质斑块.心房动是心房动的一种.认知认知认知痴呆症痴呆症是一种痴呆症.神经病理学神经病理学血管痴呆症是一种精神病.

更多相关视频

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...